Eco-friendly Synthesis of Silver Nanoparticles Using Lantana camara Extract and Their Antimicrobial Potential Against Escherichia coli
DOI:
https://doi.org/10.46966/msjar.v7i2.430Keywords:
cybersecurity, phishing, MFA fatigue, adversary-in-the-middle, detection engineering, identity telemetry, SIEM, blue team, incident responseAbstract
Background: Agar well inhibition zones combine biological response with material transport and release. Aim: We examine recorded characterization images and a four-level zone matrix for ten selected Escherichia coli isolates exposed to a Lantana camara silver preparation. Methods: The optical spectrum has a maximum near 445 nm, EDX identifies silver in the analyzed region, and five FE-SEM annotations span 55.67–91.46 nm. Results: All ten isolates show increasing visible diameters across the three higher nominal concentrations, with means of 12.79, 18.75 and 24.21 mm; five have no visible zone at the lowest concentration. Six of 45 comparable isolate pairs reverse order between the fully visible endpoints. A shared-slope log-label description has an internal omitted-dose RMSE of 1.05 mm, but does not reproduce these reversals. A finite-source mathematical model explains why endpoint zones alone cannot separately identify transport, release, growth-critical time, releasable mass and inhibitory threshold. Across 120 generated groups per mechanism, median synthetic extrapolation error increases from 0.37 to 0.76 mm under misspecified mass availability. Conclusion: An independent published matrix provides a separate example of dose-dependent isolate ordering. The case supports a descriptive concentration trend and limits on its interpretation. Regional characterization and nominal concentration labels do not establish delivered active-silver mass, nanoparticle-specific activity or clinical efficacy.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Sarmed M. Hussein, Hassan M. Mohammed, Ali Mahdi Salih

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















